Pediatric Cancer Predisposition Program
If you or someone you love is facing a cancer diagnosis, you want to find the best care as soon as possible. It is also important to know if there is a genetic component underlying your cancer. If so, other family members may be at risk, and your cancer may need specialized treatment.
The Pediatric Cancer Predisposition Program at Monroe Carell partners with the Vanderbilt-Ingram Cancer Center’s Hereditary Cancer Program to provide genetic testing, cancer risk information for other family members, screening for cancer and advice on individualizing cancer treatment.
Meet Your Care Team
Daniel J. BenedettiMD, MA
- Leukemia and Lymphoma, Pediatric Hematology/Oncology, Sarcoma, Solid Organ Malignancies
Debra L. FriedmanMD, MS
- Division of Pediatric Hematology/Oncology, General Hematology and Oncology, Leukemia and Lymphoma, Pediatric Hematology/Oncology, Solid Organ Malignancies
Why Choose Care for Cancer Predisposition at Monroe Carell
- Medical home
Our program provides a medical home for children, adolescents and young adults with suspected or confirmed cancer predisposition syndromes. When needed, we look for clues to find cancer before your child has symptoms. We also coordinate timely evaluation of symptoms that could be signs of cancer, so that your child promptly gets the care they need.
- Integrated care
In collaboration with the Vanderbilt-Ingram Cancer Center, a Comprehensive Cancer Center designated by the National Cancer Institute, our team of pediatric oncologists, cancer geneticists and genetic counselors work together to provide your child with fully integrated care.
- Advanced testing
Our team of pediatric oncologists, cancer geneticists and genetic counselors work together to provide access to state-of-the art tests for cancer predisposition syndromes. Using that information, we develop individualized plans for cancer screening and treatment.
- Referrals to specialists
We refer to other Vanderbilt specialists as needed for any condition associated with your child's cancer predisposition.